Cystinuria and other noncalcareous calculi (Q35021712)

5 August 2017

1 reference

title

Cystinuria and other noncalcareous calculi (English)

1 reference

5 August 2017

Bijan Shekarriz

1

1 reference

PubMed ID

12474640

5 August 2017

Marshall L Stoller

series ordinal

2

1 reference

5 August 2017

1 December 2002

1 reference

Endocrinology and Metabolism Clinics of North America

5 August 2017

1 reference

5 August 2017

31

1 reference

5 August 2017

4

1 reference

5 August 2017

951-977

1 reference

Intestinal Absorption and Renal Extraction of Cystine and Cysteine in Cystinuria

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

On Cystic Oxide, a New Species of Urinary Calculus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Phenotypes and genotypes in cystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Effect of penicillamine on cystinuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Localization of a gene causing cystinuria to chromosome 2p

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

High frequency of cystinuria among Jews of Libyan origin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Cystine calculi. Diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Renal clearances of amino acids in normal adults and in patients with aminoaciduria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Cystine uptake by rat renal brush-border vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Transport interaction of cystine and dibasic amino acids in renal brush border vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Transport of L-cystine in isolated perfused proximal straight tubules

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

The renal handling of amino acids and oligopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

CYSTINURIA: IN VITRO DEMONSTRATION OF AN INTESTINAL TRANSPORT DEFECT

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Cystinuria: biochemical evidence for three genetically distinct diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

The molecular bases of cystinuria and lysinuric protein intolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Acalculous cystinuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

The amino acid transport system b(o,+) and cystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Luminal heterodimeric amino acid transporter defective in cystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Expression cloning of a cDNA from rabbit kidney cortex that induces a single transport system for cystine and dibasic and neutral amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Cloning and chromosomal localization of a human kidney cDNA involved in cystine, dibasic, and neutral amino acid transport

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Expression cloning of a Na(+)-independent neutral amino acid transporter from rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Recent Advances in the Biochemical and Molecular Biological Basis of Cystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

The molecular basis of cystinuria: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Genetic heterogeneity in cystinuria: the SLC3A1 gene is linked to type I but not to type III cystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Functional analysis of mutations in SLC7A9, and genotype–phenotype correlation in non-Type I cystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Cystinuria calls for heteromultimeric amino acid transporters.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Human cystinuria-related transporter: localization and functional characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Molecular biology of mammalian plasma membrane amino acid transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi. The American Urological Association Nephrolithiasis Clinical Guidelines Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Contemporary management of cystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Cystinuria, hyperuricemia and uric acid nephrolithiasis. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Homozygous Cystinuria—Evaluation of 35 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Stone fragility--a new therapeutic distinction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Dietary restriction of sodium as a means of reducing urinary cystine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Anticystinuric effects of glutamine and of dietary sodium restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Medical treatment of cystinuria: critical reappraisal of long-term results.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Effect of Glutamine on Cystine Excretion in a Patient with Cystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Cystine calculi--rough and smooth: a new clinical distinction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

A strategy of cystine stone management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Combination of chemolysis and shock wave lithotripsy in the treatment of cystine renal calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

The Swiss Lithoclast: a new device for endoscopic stone disintegration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Use of Swiss Lithoclast for percutaneous nephrolithotripsy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

1 reference

7 January 2021

Effect of ammonium on bacterial adherence to bladder transitional epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Treatment options in struvite stones

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Nonsurgical management of infection-related renal calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Metabolic evaluation of infected renal lithiasis: clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

The Case for a More Aggressive Approach to Staghorn Stones

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Retrospective study of 95 patients with staghorn calculus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Randomized, Double-Blind Trial of Lithostat™ (Acetohydroxamic Acid) in the Palliative Treatment of Infection-Induced Urinary Calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal cord injury patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

The Clinical Use of Renacidin in Urinary Calcifications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Chemolysis of urinary calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Hypermagnesemia in a Uremic Patient During Renal Pelvis Irrigation with Renacidin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Adjunctive chemotherapy of infection-induced staghorn calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Management of infection stones: the Stanford experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

1 reference

7 January 2021

Long-term efficacy of combination therapy for struvite staghorn calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Organic matrix of human urinary concretions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

1 reference

7 January 2021

Triamterene and renal stones.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

Indinavir urinary stones as origin of upper urinary tract obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900054-3

7 January 2021

10.1016/S0889-8529(02)00054-3

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12474640